Patient A Osteosarcoma Units Date                            
Test   11/19/2004 1/11/2005 3/21/2005 6/22/2005 7/15/2005   9/19/2005 9/27/2005 11/22/2005 1/24/2006 3/21/2006        
WBC 4800-10800   8100 6100 8100   WBC 5700   6300   6700        
Lymphocyte 960-4320 1800 1782 1891 2673   Lymphocyte 1596   1323 2020 1943        
% Lymphocyte 20-40%   22 31 33   % Lymphocyte 28   21   29        
Total T Cell  336-2376 756 1420 1405 2076   Total T Cell  1181   988 1535 1470        
% T Cell (T11, CD2) 61-85%   80 74 78   % T Cell (T11, CD2) 74   75 76 76        
Total T Helper Cell (T4) 336-2376   820 813 1176   Total T Helper Cell (T4) 718   556 705 855        
% T Helper Cell (T4) 35-55% 42 46 43 44   % T Helper Cell (T4) 45   42 42 44        
Total Suppressor Cell 192-1598 486 535 529 829   Total Suppressor Cell 431   397   563        
% Suppressor Cell (T8) 20-37% 27 30 28 31   % Suppressor Cell (T8) 27   30 31 29        
T Helper/T-Suppressor 1-2.5 1.6 1.5 1.5 1.4   T Helper/T-Suppressor 1.7   1.4 1.35 1.5        
Total B Cell 48-648 288 214 303 428   Total B Cell 255   172   253        
% B Cell (B1, CD20) 006-29 16 12 16 16   % B Cell (B1, CD20) 16   13   13        
Total Natural Killer 52-864 162 178 227 213   Total Natural Killer 192   186   253        
% Natural Killer Cells 5.5-20% 9 10 12 8   % Natural Killer Cells 12   14   13        
Total Immunocompetent 14-216   18 38 53   Total Immunocompetent 48   40   39        
% Immunocompetent-NKHT3+ 1.5-5%   1 2 2   % Immunocompetent-NKHT3+ 3   3   2        
Total NKHT3 Negative 38-648   160 189 160   Total NKHT3 Negative 144   146   214        
% NKHT3 Negative 4-15%   9 10 6   % NKHT3 Negative 9   11   11        
Total CD3+ CD26+ 10-1944   838 813 1203   Total CD3+ CD26+ 718   609   816        
% CD3+ CD26+ (TA1) 1-45%   47 43 45   % CD3+ CD26+ (TA1) 45   46   42        
Total T3 (CD3) Positive C 509-3413   1372 1381 2058   Total T3 (CD3) Positive C 1213   1006   1457        
% T3 Positive Cells 53-79%   77 73 77   % T3 Positive Cells 76   76   75        
Interleukin-2 Production 0.13-1.10   0.1 0.1 1.4   Interleukin-2 Production 1.1   1   <31.2        
NK Cell Activity 20-50   12.1 13.2 2.4   NK Cell Activity 4.45   40.9   24.6        
NK Cell Activity/Cell 5.1-10   6.8 5.8 1.1   NK Cell Activity/Cell 2.31   22   9.7        
% Natural Killer Cells 5.5-20%   10 12 8   % Natural Killer Cells 12   14   13        
% Immunocompetent-NKHT3+ 1.5-5%   1 2 2   % Immunocompetent-NKHT3+ 3   3   2        
%NKHT3 Negative 4-15%   9 10 6   %NKHT3 Negative 9   11   11        
Phytohemagglutinin 75-125%   114 115 33   Phytohemagglutinin 177   99   4        
Concanavalin A 75-125%   85 34 52   Concanavalin A 121   120  
Pokeweed Mitogen 75-125%   101 84 57   Pokeweed Mitogen 158   89   2        
Lipopolysaccharide 75-125%   101 84 55   Lipopolysaccharide 161   89  
Interleukin-2 Level 0.13-1.10   0.1 0.1  
Interferon Gamma (2-20pg/ml production) 0.1-1.35   0.48 0.03 0.03 production   Interferon Gamma (2-20pg/ml production) 5.1  
Interleukin-4 0.3-1.3   1.3 0.27  
Interleukin-10 1.00-5.00   1 1  
Interleukin-6   2.44   18.2 <2.0  
Interleukin-2 Receptor 94-829.6U/ml   456  
D-Dimer <0.4ug/ml   0.3     <0.2  
C-reactive Protein 0-6 mg/L   0.5  
12/9/2004 2/10/2005 4/25/2005   7/15/2005 10/4/2005  
Astr: 1 bid 3 bid   dc  
Reishi: 4 bid x x   dc  
Immuno: 4 bid 4 tid x   x dc  
Eleu: 4 bid x   Am Gin: 4qd x  
Cel tinc:  Not taking Celandine   1t bid x  
Brom: 5 bid x x   5 bid x  
Catalytic: 10bid x x   7 bid x  
Lakto: 6hs x x   dc  
Curcu: 1 bid 4 bid x   2 q 3/4 hr 4 doses x  
Vascu: 6bid x  
Modu: 3 bid x  
Cori: 3 bid  
Cord: 3 bid   4 qd in am x  
Se: 2  
Immun'a: 3pkt  
Limonene: 1/2-1t tid 2 caps tid  
Minor Bup: 1 tid  
Ultra potent: 1 T/d  
Melatonin: 20mg  
Ellagic: 6-10 caps x  
    11/18/2004 2/2/2005 6/22/2005 10/14/2005 2/6/2006    
VEGF 31-86 <31   162 68 50    
IGF-1 114-492 193        
Immune Complex, C1q   <1.2  
IGF-Binding Protein-3 02-004 2.2  
Ceruloplasmin   31  
Copper   1214  
Hemoglobin   15.1  
Hematocrit   44  
40tid, 60hs